Company intelligence / Profile preview
St. Renatus, LLC
Fort Collins, Colorado, United Stateslinkedin.com ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Commercial
01
Overview
Kovanaze® Nasal Spray received FDA approval in June 2016 as the first needle-free dental anesthetic administered via nasal spray for use in dentistry. It provides regional pulpal anesthesia for certain upper teeth during restorative procedures without the need for traditional needle injections
- Therapeutic areas
- Other
- Modalities
- Small molecules (combination drug product—tetracaine HCl and oxymetazoline HCl)
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on St. Renatus, LLC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on St. Renatus, LLC.